New AACE Guidelines for Non-Alcoholic Fatty Liver Disease - Frankly Speaking Ep 302 - a podcast by Pri-Med
from 2022-11-14T00:30
::
::
Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-302
Overview: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States, with a prevalence rate of more than 30% of US adults. Most have not been diagnosed or treated. Join us to discuss the new AACE guidance on the diagnosis and treatment of NAFLD to reduce the burden of this common disease.
Episode resource links:
- AACE Guideline: Endocrine Pract: May 2022, 28(5): 528-562
- Coffee: Front Pharmacol. 2021 Dec 13;12:786596. doi: 10.3389/fphar.2021.786596
Guest: Robert A. Baldor, MD
Music Credit: Richard Onorato
Further episodes of Pri-Med Podcasts
Further podcasts by Pri-Med
Website of Pri-Med